AAAAAA

   
Results: 1-9 |
Results: 9
Development of a dual monoclonal antibody immunoassay for total human kallikrein 2
Authors: Finlay, JA Day, JR Evans, CL Carlson, R Kuus-Reichel, K Millar, LS Mikolajczyk, SD Goodmanson, M Klee, GG Rittenhouse, HG
Citation: Ja. Finlay et al., Development of a dual monoclonal antibody immunoassay for total human kallikrein 2, CLIN CHEM, 47(7), 2001, pp. 1218-1224
A truncated precursor form of prostate-specific antigen is a more specificserum marker of prostate cancer
Authors: Mikolajczyk, SD Marker, KM Millar, LS Kumar, A Saedi, MS Payne, JK Evans, CL Gasior, CL Linton, HJ Carpenter, P Rittenhouse, HG
Citation: Sd. Mikolajczyk et al., A truncated precursor form of prostate-specific antigen is a more specificserum marker of prostate cancer, CANCER RES, 61(18), 2001, pp. 6958-6963
Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia
Authors: Mikolajczyk, SD Millar, LS Marker, KM Wang, TJ Rittenhouse, HG Marks, LS Slawin, KM
Citation: Sd. Mikolajczyk et al., Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia, PROSTATE, 45(3), 2000, pp. 271-276
Different proportions of various prostate-specific antigen (PSA) and humankallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells
Authors: Kumar, A Mikolajczyk, SD Hill, TM Millar, LS Saedi, MS
Citation: A. Kumar et al., Different proportions of various prostate-specific antigen (PSA) and humankallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells, PROSTATE, 44(3), 2000, pp. 248-254
"BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia
Authors: Mikolajczyk, SD Millar, LS Wang, TJ Rittenhouse, HG Wolfert, RL Marks, LS Song, WT Wheeler, TM Slawin, KM
Citation: Sd. Mikolajczyk et al., "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia, UROLOGY, 55(1), 2000, pp. 41-45
Benign prostatic hyperplasia-associated prostate-specific antigen (BPSA) shows unique immunoreactivity with anti-PSA monoclonal antibodies
Authors: Wang, TJ Slawin, KM Rittenhouse, HG Millar, LS Mikolajczyk, SD
Citation: Tj. Wang et al., Benign prostatic hyperplasia-associated prostate-specific antigen (BPSA) shows unique immunoreactivity with anti-PSA monoclonal antibodies, EUR J BIOCH, 267(13), 2000, pp. 4040-4045
A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue
Authors: Mikolajczyk, SD Millar, LS Wang, TJ Rittenhouse, HG Marks, LS Song, WT Wheeler, TM Slawin, KM
Citation: Sd. Mikolajczyk et al., A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue, CANCER RES, 60(3), 2000, pp. 756-759
Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1
Authors: Mikolajczyk, SD Millar, LS Kumar, A Saedi, MS
Citation: Sd. Mikolajczyk et al., Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1, INT J CANC, 81(3), 1999, pp. 438-442
Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue
Authors: Mikolajczyk, SD Millar, LS Marker, KM Rittenhouse, HG Wolfert, RL Marks, LS Charlesworth, MC Tindall, DJ
Citation: Sd. Mikolajczyk et al., Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue, CANCER RES, 59(16), 1999, pp. 3927-3930
Risultati: 1-9 |